Extracorporeal cytokine adsorption: Significant reduction of catecholamine requirement in patients with AKI and septic shock after cardiac surgery.

<h4>Background</h4>Extracorporeal cytokine adsorption is an option in septic shock as an additional measure to treat a pathological immune response. Purpose of this study was to investigate the effects of extracorporeal cytokine adsorption on hemodynamic parameters in patients with acute...

Full description

Bibliographic Details
Main Authors: Kristina Boss, Michael Jahn, Daniel Wendt, Zaki Haidari, Ender Demircioglu, Matthias Thielmann, Arjang Ruhparwar, Andreas Kribben, Bartosz Tyczynski
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0246299
id doaj-a3fc76d65d424c43828abcca14dedbf6
record_format Article
spelling doaj-a3fc76d65d424c43828abcca14dedbf62021-07-29T04:32:39ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01162e024629910.1371/journal.pone.0246299Extracorporeal cytokine adsorption: Significant reduction of catecholamine requirement in patients with AKI and septic shock after cardiac surgery.Kristina BossMichael JahnDaniel WendtZaki HaidariEnder DemirciogluMatthias ThielmannArjang RuhparwarAndreas KribbenBartosz Tyczynski<h4>Background</h4>Extracorporeal cytokine adsorption is an option in septic shock as an additional measure to treat a pathological immune response. Purpose of this study was to investigate the effects of extracorporeal cytokine adsorption on hemodynamic parameters in patients with acute kidney injury (AKI) on continuous renal replacement therapy (CRRT) and septic shock after cardiac surgery.<h4>Methods</h4>In this retrospective study, a total of 98 patients were evaluated. Hemoadsorption was performed by the CytoSorb® adsorber. In all patients cytokine adsorption was applied for at least 15 hours and at least one adsorber was used per patient. To compare cumulative inotrope need in order to maintain a mean arterial pressure (MAP) of ≥ 65 mmHg, we applied vasoactive score (VAS) for each patient before and after cytokine adsorption. A paired t-test has been performed to determine statistical significance.<h4>Results</h4>Before cytokine adsorption the mean VAS was 56.7 points. This was statistically significant decreased after cytokine adsorption (27.7 points, p< 0.0001). Before cytokine adsorption, the mean noradrenalin dose to reach a MAP of ≥ 65 mmHg was 0.49 μg/kg bw/min, the mean adrenalin dose was 0.12 μg/kg bw/min. After cytokine adsorption, significantly reduced catecholamine doses were necessary to maintain a MAP of ≥ 65 mmHg (0.24 μg/kg bw/min noradrenalin; p< 0.0001 and 0.07 μg/kg bw/min adrenalin; p < 0.0001). Moreover, there was a significant reduction of serum lactate levels after treatment (p< 0.0001). The mean SOFA-score for these patients with septic shock and AKI before cytokine adsorption was 16.7 points, the mean APACHE II-score was 30.2 points. The mean predicted in-hospital mortality rate based on this SOFA-score of 16.7 points was 77,0%, respectively 73,0% on APACHE II-score, while the all-cause in-hospital mortality rate of the patients in this study was 59.2%.<h4>Conclusion</h4>In patients with septic shock and AKI undergoing cardiac surgery, extracorporeal cytokine adsorption could significantly lower the need for postoperative inotropes. Additionally, observed versus SOFA- and APACHE II-score predicted in-hospital mortality rate was decreased.https://doi.org/10.1371/journal.pone.0246299
collection DOAJ
language English
format Article
sources DOAJ
author Kristina Boss
Michael Jahn
Daniel Wendt
Zaki Haidari
Ender Demircioglu
Matthias Thielmann
Arjang Ruhparwar
Andreas Kribben
Bartosz Tyczynski
spellingShingle Kristina Boss
Michael Jahn
Daniel Wendt
Zaki Haidari
Ender Demircioglu
Matthias Thielmann
Arjang Ruhparwar
Andreas Kribben
Bartosz Tyczynski
Extracorporeal cytokine adsorption: Significant reduction of catecholamine requirement in patients with AKI and septic shock after cardiac surgery.
PLoS ONE
author_facet Kristina Boss
Michael Jahn
Daniel Wendt
Zaki Haidari
Ender Demircioglu
Matthias Thielmann
Arjang Ruhparwar
Andreas Kribben
Bartosz Tyczynski
author_sort Kristina Boss
title Extracorporeal cytokine adsorption: Significant reduction of catecholamine requirement in patients with AKI and septic shock after cardiac surgery.
title_short Extracorporeal cytokine adsorption: Significant reduction of catecholamine requirement in patients with AKI and septic shock after cardiac surgery.
title_full Extracorporeal cytokine adsorption: Significant reduction of catecholamine requirement in patients with AKI and septic shock after cardiac surgery.
title_fullStr Extracorporeal cytokine adsorption: Significant reduction of catecholamine requirement in patients with AKI and septic shock after cardiac surgery.
title_full_unstemmed Extracorporeal cytokine adsorption: Significant reduction of catecholamine requirement in patients with AKI and septic shock after cardiac surgery.
title_sort extracorporeal cytokine adsorption: significant reduction of catecholamine requirement in patients with aki and septic shock after cardiac surgery.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2021-01-01
description <h4>Background</h4>Extracorporeal cytokine adsorption is an option in septic shock as an additional measure to treat a pathological immune response. Purpose of this study was to investigate the effects of extracorporeal cytokine adsorption on hemodynamic parameters in patients with acute kidney injury (AKI) on continuous renal replacement therapy (CRRT) and septic shock after cardiac surgery.<h4>Methods</h4>In this retrospective study, a total of 98 patients were evaluated. Hemoadsorption was performed by the CytoSorb® adsorber. In all patients cytokine adsorption was applied for at least 15 hours and at least one adsorber was used per patient. To compare cumulative inotrope need in order to maintain a mean arterial pressure (MAP) of ≥ 65 mmHg, we applied vasoactive score (VAS) for each patient before and after cytokine adsorption. A paired t-test has been performed to determine statistical significance.<h4>Results</h4>Before cytokine adsorption the mean VAS was 56.7 points. This was statistically significant decreased after cytokine adsorption (27.7 points, p< 0.0001). Before cytokine adsorption, the mean noradrenalin dose to reach a MAP of ≥ 65 mmHg was 0.49 μg/kg bw/min, the mean adrenalin dose was 0.12 μg/kg bw/min. After cytokine adsorption, significantly reduced catecholamine doses were necessary to maintain a MAP of ≥ 65 mmHg (0.24 μg/kg bw/min noradrenalin; p< 0.0001 and 0.07 μg/kg bw/min adrenalin; p < 0.0001). Moreover, there was a significant reduction of serum lactate levels after treatment (p< 0.0001). The mean SOFA-score for these patients with septic shock and AKI before cytokine adsorption was 16.7 points, the mean APACHE II-score was 30.2 points. The mean predicted in-hospital mortality rate based on this SOFA-score of 16.7 points was 77,0%, respectively 73,0% on APACHE II-score, while the all-cause in-hospital mortality rate of the patients in this study was 59.2%.<h4>Conclusion</h4>In patients with septic shock and AKI undergoing cardiac surgery, extracorporeal cytokine adsorption could significantly lower the need for postoperative inotropes. Additionally, observed versus SOFA- and APACHE II-score predicted in-hospital mortality rate was decreased.
url https://doi.org/10.1371/journal.pone.0246299
work_keys_str_mv AT kristinaboss extracorporealcytokineadsorptionsignificantreductionofcatecholaminerequirementinpatientswithakiandsepticshockaftercardiacsurgery
AT michaeljahn extracorporealcytokineadsorptionsignificantreductionofcatecholaminerequirementinpatientswithakiandsepticshockaftercardiacsurgery
AT danielwendt extracorporealcytokineadsorptionsignificantreductionofcatecholaminerequirementinpatientswithakiandsepticshockaftercardiacsurgery
AT zakihaidari extracorporealcytokineadsorptionsignificantreductionofcatecholaminerequirementinpatientswithakiandsepticshockaftercardiacsurgery
AT enderdemircioglu extracorporealcytokineadsorptionsignificantreductionofcatecholaminerequirementinpatientswithakiandsepticshockaftercardiacsurgery
AT matthiasthielmann extracorporealcytokineadsorptionsignificantreductionofcatecholaminerequirementinpatientswithakiandsepticshockaftercardiacsurgery
AT arjangruhparwar extracorporealcytokineadsorptionsignificantreductionofcatecholaminerequirementinpatientswithakiandsepticshockaftercardiacsurgery
AT andreaskribben extracorporealcytokineadsorptionsignificantreductionofcatecholaminerequirementinpatientswithakiandsepticshockaftercardiacsurgery
AT bartosztyczynski extracorporealcytokineadsorptionsignificantreductionofcatecholaminerequirementinpatientswithakiandsepticshockaftercardiacsurgery
_version_ 1721259475626622976